185 related articles for article (PubMed ID: 21564095)
1. Neuroprotective role of fibroblast growth factor-2 in experimental autoimmune encephalomyelitis.
Rottlaender A; Villwock H; Addicks K; Kuerten S
Immunology; 2011 Jul; 133(3):370-8. PubMed ID: 21564095
[TBL] [Abstract][Full Text] [Related]
2. FGF/FGFR Pathways in Multiple Sclerosis and in Its Disease Models.
Rajendran R; Böttiger G; Stadelmann C; Karnati S; Berghoff M
Cells; 2021 Apr; 10(4):. PubMed ID: 33924474
[TBL] [Abstract][Full Text] [Related]
3. Basic FGF and FGF receptor 1 are expressed in microglia during experimental autoimmune encephalomyelitis: temporally distinct expression of midkine and pleiotrophin.
Liu X; Mashour GA; Webster HF; Kurtz A
Glia; 1998 Dec; 24(4):390-7. PubMed ID: 9814819
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice.
Ruffini F; Furlan R; Poliani PL; Brambilla E; Marconi PC; Bergami A; Desina G; Glorioso JC; Comi G; Martino G
Gene Ther; 2001 Aug; 8(16):1207-13. PubMed ID: 11509953
[TBL] [Abstract][Full Text] [Related]
5. Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.
Petratos S; Ozturk E; Azari MF; Kenny R; Lee JY; Magee KA; Harvey AR; McDonald C; Taghian K; Moussa L; Mun Aui P; Siatskas C; Litwak S; Fehlings MG; Strittmatter SM; Bernard CC
Brain; 2012 Jun; 135(Pt 6):1794-818. PubMed ID: 22544872
[TBL] [Abstract][Full Text] [Related]
6. Oestrogen receptor β ligand acts on CD11c+ cells to mediate protection in experimental autoimmune encephalomyelitis.
Kim RY; Mangu D; Hoffman AS; Kavosh R; Jung E; Itoh N; Voskuhl R
Brain; 2018 Jan; 141(1):132-147. PubMed ID: 29228214
[TBL] [Abstract][Full Text] [Related]
7. Fc receptors are critical for autoimmune inflammatory damage to the central nervous system in experimental autoimmune encephalomyelitis.
Abdul-Majid KB; Stefferl A; Bourquin C; Lassmann H; Linington C; Olsson T; Kleinau S; Harris RA
Scand J Immunol; 2002 Jan; 55(1):70-81. PubMed ID: 11841694
[TBL] [Abstract][Full Text] [Related]
8. IL4I1 augments CNS remyelination and axonal protection by modulating T cell driven inflammation.
Psachoulia K; Chamberlain KA; Heo D; Davis SE; Paskus JD; Nanescu SE; Dupree JL; Wynn TA; Huang JK
Brain; 2016 Dec; 139(Pt 12):3121-3136. PubMed ID: 27797811
[TBL] [Abstract][Full Text] [Related]
9. Alterations of peripheral nerve excitability in an experimental autoimmune encephalomyelitis mouse model for multiple sclerosis.
Teixeira NB; Picolo G; Giardini AC; Boumezbeur F; Pottier G; Kuhnast B; Servent D; Benoit E
J Neuroinflammation; 2020 Sep; 17(1):266. PubMed ID: 32894170
[TBL] [Abstract][Full Text] [Related]
10. Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway.
Linker RA; Lee DH; Ryan S; van Dam AM; Conrad R; Bista P; Zeng W; Hronowsky X; Buko A; Chollate S; Ellrichmann G; Brück W; Dawson K; Goelz S; Wiese S; Scannevin RH; Lukashev M; Gold R
Brain; 2011 Mar; 134(Pt 3):678-92. PubMed ID: 21354971
[TBL] [Abstract][Full Text] [Related]
11. Oligodendroglial TNFR2 Mediates Membrane TNF-Dependent Repair in Experimental Autoimmune Encephalomyelitis by Promoting Oligodendrocyte Differentiation and Remyelination.
Madsen PM; Motti D; Karmally S; Szymkowski DE; Lambertsen KL; Bethea JR; Brambilla R
J Neurosci; 2016 May; 36(18):5128-43. PubMed ID: 27147664
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of fibroblast growth factor-2 and receptor by glial cells in experimental autoimmune encephalomyelitis (EAE).
Gehrmann J; Lannes-Vieira J; Wekerle H
Glia; 1996 Feb; 16(2):93-100. PubMed ID: 8929896
[TBL] [Abstract][Full Text] [Related]
13. The epigenetic drug Trichostatin A ameliorates experimental autoimmune encephalomyelitis via T cell tolerance induction and impaired influx of T cells into the spinal cord.
Jayaraman A; Soni A; Prabhakar BS; Holterman M; Jayaraman S
Neurobiol Dis; 2017 Dec; 108():1-12. PubMed ID: 28736194
[TBL] [Abstract][Full Text] [Related]
14. IL-11 regulates autoimmune demyelination.
Gurfein BT; Zhang Y; López CB; Argaw AT; Zameer A; Moran TM; John GR
J Immunol; 2009 Oct; 183(7):4229-40. PubMed ID: 19734214
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination.
Brambilla R; Ashbaugh JJ; Magliozzi R; Dellarole A; Karmally S; Szymkowski DE; Bethea JR
Brain; 2011 Sep; 134(Pt 9):2736-54. PubMed ID: 21908877
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of a novel cannabinoid agent CB52 in the mouse model of experimental autoimmune encephalomyelitis.
Ribeiro R; Yu F; Wen J; Vana A; Zhang Y
Neuroscience; 2013 Dec; 254():427-42. PubMed ID: 24036373
[TBL] [Abstract][Full Text] [Related]
17. Epigallocatechin-3-gallate ameliorates experimental autoimmune encephalomyelitis by altering balance among CD4+ T-cell subsets.
Wang J; Ren Z; Xu Y; Xiao S; Meydani SN; Wu D
Am J Pathol; 2012 Jan; 180(1):221-34. PubMed ID: 22056360
[TBL] [Abstract][Full Text] [Related]
18. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination.
Gran B; Zhang GX; Yu S; Li J; Chen XH; Ventura ES; Kamoun M; Rostami A
J Immunol; 2002 Dec; 169(12):7104-10. PubMed ID: 12471147
[TBL] [Abstract][Full Text] [Related]
19. Astrocytes produce CNTF during the remyelination phase of viral-induced spinal cord demyelination to stimulate FGF-2 production.
Albrecht PJ; Murtie JC; Ness JK; Redwine JM; Enterline JR; Armstrong RC; Levison SW
Neurobiol Dis; 2003 Jul; 13(2):89-101. PubMed ID: 12828933
[TBL] [Abstract][Full Text] [Related]
20. Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis.
Linker RA; Lee DH; Demir S; Wiese S; Kruse N; Siglienti I; Gerhardt E; Neumann H; Sendtner M; Lühder F; Gold R
Brain; 2010 Aug; 133(Pt 8):2248-63. PubMed ID: 20826430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
